<?xml version="1.0" encoding="ISO-8859-1"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level2.owl#" xmlns="http://www.phidias.us/biopax#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:daml="http://www.daml.org/2001/03/daml+oil#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <owl:Ontology rdf:about="">
    <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level2.owl"/>
  </owl:Ontology>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Enzyme">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Eukaryotic_cell_or_cell_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eukaryotic cell or cell component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Microbe-host_cell_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Microbe-host cell complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Microorganism_or_its_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Microorganism or its component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Other_--_ion">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other -- ion</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Pathway_or_action">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway or action</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_gene">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or gene</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_gene_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or gene complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_protein_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or protein complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Bacterial_membrane_or_virus_envelope">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bacterial membrane or virus envelope</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Cytoplasm">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cytoplasm</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Eukaryotic_cell_or_cell_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eukaryotic cell or cell component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Extracellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Extracellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Golgi">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Golgi</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Golgi_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Golgi membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Intercellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Intercellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Intracellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Intracellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Mitochondria">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mitochondria</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Nucleocapsid/Cytoplasm">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleocapsid/Cytoplasm</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Endoplasmic_reticulum">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Endoplasmic reticulum</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_ER">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- ER</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Golgi">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Golgi</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Golgi_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Golgi membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Nucleus">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Nucleus</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Phagolysosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Phagolysosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Phagosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Phagosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Ribosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Ribosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Phagolysosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phagolysosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Phagosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phagosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Chaperone">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chaperone</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Defense,_immunity_protein">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Defense, immunity protein</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme_activator">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme activator</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme_inhibitor">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme inhibitor</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Genomic_S_segment">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genomic S segment</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Infection">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Infection</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Ligand_binding_or_carrier">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand binding or carrier</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Motor">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Motor</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Nucleic_acid_binding">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleic acid binding</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Signal_transducer">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Signal transducer</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Toxicity">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Toxicity</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transcription_factor_binding">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transcription factor binding</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transcription_regulation">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transcription regulation</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transporter">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transporter</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Unknown">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Unknown</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:evidence rdf:ID="evidence_IC">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IC">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IC</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred by Curator</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IDA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IDA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IDA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Direct Assay</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IEA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IEA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IEA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Electronic Annotation</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IEP">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IEP">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IEP</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Expression Pattern</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IGI">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IGI">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IGI</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Genetic Interaction</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IMP">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IMP">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IMP</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Mutant Phenotype</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IPI">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IPI">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IPI</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Physical Interaction</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_ISS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_ISS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ISS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Sequence or Structural Similarity</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_NAS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_NAS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NAS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Non-traceable Author Statement</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_ND">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_ND">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ND</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">No biological Data available</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_RCA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_RCA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">RCA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">inferred from Reviewed Computational Analysis</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_TAS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_TAS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">TAS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Traceable Author Statement</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_NR">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_NR">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NR</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Not Recorded</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:publicationXref rdf:ID="reference5346">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Keelapang P, Sriburi R, Supasa S, Panyadee N, Songjaeng A, Jairungsri A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14963133</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5340">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lobigs M, Lee E</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14671099</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5336">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Anderson R</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Advances in virus research</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Manipulation of cell surface macromolecules by flaviviruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14696331</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5345">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Galler R, Freire MS, Jabor AV, Mann GF</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.]</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The yellow fever 17D vaccine virus: molecular basis of viral attenuation and its use as an expression vector</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1997</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9239300</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5341">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Westaway EG, Mackenzie JM, Khromykh AA</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Advances in virus research</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kunjin RNA replication and applications of Kunjin replicons</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14696328</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5349">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wu CF, Wang SH, Sun CM, Hu ST, Syu WJ</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virological methods</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activation of dengue protease autocleavage at the NS2B-NS3 junction by recombinant NS3 and GST-NS2B fusion proteins</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14599678</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5347">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kummerer BM, Rice CM</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11967294</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5344">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gehrke R, Ecker M, Aberle SW, Allison SL, Heinz FX, Mandl CW</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12885909</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5342">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kapoor M, Zhang L, Ramachandra M, Kusukawa J, Ebner KE, Padmanabhan R</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Journal of biological chemistry</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">199511</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7642575</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5338">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bartholomeusz A, Thompson P</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of viral hepatitis</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Flaviviridae polymerase and RNA replication</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10607240</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5348">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhang Y, Corver J, Chipman PR, Zhang W, Pletnev SV, Sedlak D, Baker TS, Strauss JH, Kuhn RJ, Rossmann MG</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The EMBO journal</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Structures of immature flavivirus particles</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">20032</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12773377</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5339">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mukhopadhyay S, Kuhn RJ, Rossmann MG</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nature reviews. Microbiology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A structural perspective of the flavivirus life cycle</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2005</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15608696</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5343">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Heinz FX, Stiasny K, Allison SL</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Archives of virology. Supplementum</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The entry machinery of flaviviruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15119768</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5335">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lindenbach BD, Rice CM</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Advances in virus research</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular biology of flaviviruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14696326</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5330">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hase T, Summers PL, Eckels KH</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Archives of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1989</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2564270</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5331">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chu JJ, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng ML</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Journal of general virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2005</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15659760</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5333">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Thepparit C, Smith DR</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2004</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15507651</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5332">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vlaycheva L, Nickells M, Droll DA, Chambers TJ</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">200415</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15327896</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5350">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lindenbach BD and Rice CM</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Field&#8217;s Virology, Fourth Edition Volume One</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Flaviviridae:  The Viruses and Their Replication</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
  </bp:publicationXref>

  <bp:physicalEntityParticipant rdf:ID="bioobject_324">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">E protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Ligand binding or carrier.
The E protein is the major surface protein of the viral particle, probably interacts with viral receptors, and mediates virus-cell membrane fusion (Lindenbach and Rice, 2001).  The flavivirus major envelope glycoprotein has a dual function: as a receptor binding protein, it is the primary determinant of host range, cell tropism, virulence and is a major antigen in eliciting neutralizing antibodies during the immune response  (Chu et al., 2005).  Based on the structure of the soluble fragment of the tick-borne encephalitis (TBE) virus E protein,  domain III has been implicated in binding to cellular receptors. Consequently, some of the virulence determinants that affect the pathogenesis of flaviviruses in animal models have been mapped to the lateral edge of this domain, and these act presumably through effects on virus attachment, post-receptor-binding events associated with virus entry, or both (Vlaycheva et al., 2004).(<a href="#reference5350">Lindenbach</a>)(<a href="#reference5332">Vlaycheva et al., 2004</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_325">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell receptor(s)</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Ligand binding or carrier.
It is thought that flaviviruses attach to the surface of host cells through an interaction of the E protein with one or more receptors,and many E-reactive antibodies have been shown to neutralize virus infectivity by interfering with virus binding (Lindenbach and Rice, 2001).  Entry of the dengue virus serotype 1 was significantly inhibited in a dose-dependent manner by both antibodies directed against the 37/67-kDa high-affinity laminin receptor and soluble laminin. No inhibition of virus entry was seen with dengue virus serotypes 2, 3, or 4, demonstrating that the 37/67-kDa high-affinity laminin receptor is a serotype-specific receptor for dengue virus entry into liver cells (Thepparit and Smith, 2004).  Our data implicate the {alpha}v{beta}3 integrin, a prominent endothelial cell receptor, as the functional receptor and the associated signaling pathway necessary for WNV entry into vertebrate cells (Chu et al., 2004).(<a href="#reference5350">Lindenbach</a>)(<a href="#reference5333">Thepparit et al., 2004</a>)(<a href="#reference5331">Chu et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_326">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Attached virion</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
It is thought that flaviviruses attach to the surface of host cells through an interaction of the E protein with one or more receptors,and many E-reactive antibodies have been shown to neutralize virus infectivity by interfering with virus binding (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_327">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virion in cytoplasm</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
After binding, it is generally believed that virions are taken up by receptor-mediated endocytosis, although direct fusion at the plasma membrane has also been observed (Lindenbach and Rice, 2001).  The entry modes of Japanese encephalitis (JE) and dengue-2 (DEN-2) viruses into C6/36 mosquito cells and of DEN-2 virus into human peripheral blood monocytes in vitro were studied. Inoculation of either JE or DEN-2 virions into C6/36 cells resulted in direct penetration of the virions into the cytoplasm at the cell surface in 3 stages. At stage 1, virions attached to the plasma membrane of host cells by their envelope spikes; at stage 2, the virion envelopes approximated to and eventually overlapped the host plasma membrane, and in the process the plasma membrane at the attachment sites dissolved; and, at stage 3, virions penetrated into the cytoplasm through the plasma-membrane disruptions created at the adsorption sites. Virions themselves apparently disintegrated at or near the penetration sites, for no virions were seen in the deeper cytoplasm (Hase et al., 1989).(<a href="#reference5350">Lindenbach</a>)(<a href="#reference5330">Hase et al., 1989</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_328">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virion in Phagolysosome</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Phagolysosome"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virions are internalized into clathrin-coated pits via receptor-mediated endocytosis.  It is thought that virions are brought into a prelysosomal endocytic compartment where low pH induces fusion between the virus and host cell membranes to release the virus nucleocapsid (Lindenbach and Rice, 2003).(<a href="#reference5335">Lindenbach et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_329">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fused virion</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Phagolysosome"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virions are later found in uncoated pre-lysosomal vesicles, where an acid-catalyzed membrane fusion is thought to release the nucleocapsid into the cytoplasm.  Consistent with this, a conformational change in the viral E proteins, which probably exposes a fusogenic domain, occurs at low pH.  Acid pH can promote fusion of virions with liposomal membranes in vitro or at the plasma membrane of cultured cells, although in the latter case this mode of entry does not lead to productive infection (Lindenbach and Rice, 2001).  In vitro fusion experiments with pyrene phospholipid-labeled TBEV and artificial liposomes have revealed that the fusion reaction of this virus is a very facile process, occurring faster than that of any other enveloped virus analyzed to date.  Exposure of the virus to acidic pH causes dramatic structural changes in the viral fusion protein E that also leads to a quantitative oligomeric switch from dimers to trimers.  These changes are irreversible and apparently drive the fusion process (Heinz et al., 2004).(<a href="#reference5350">Lindenbach</a>)(<a href="#reference5343">Heinz et al., 2004</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_330">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleocapsid</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The isometric nucleocapsid is composed of a single capsid protein (C) and contains the plus-stranded RNA genome of approximately 11,000 nucleotides (Heinz et al., 2004).  Following entry and fusion, nucleocapsids are presumably disassembled, genomic RNA is translated, and RNA is initiated (Lindenbach and Rice, 2001).  After fusion has occurred, the NC is released into the cytoplasm, the capsid protein and RNA dissociate, and replication of the RNA genome and particle assembly is initiated (Mukhopadhyay et al., 2005).(<a href="#reference5343">Heinz et al., 2004</a>)(<a href="#reference5350">Lindenbach</a>)(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_331">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Capsid Protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
After fusion has occurred, the NC is released into the cytoplasm, the capsid protein and RNA dissociate, and replication of the RNA genome and particle assembly is initiated (Mukhopadhyay et al., 2005).(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_332">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genomic RNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Following entry and fusion, nucleocapsids are presumably disassembled, genomic RNA is translated, and RNA is initiated (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_333">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Antigenomic RNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The 5' noncoding region (NCR) sequence is poorly conserved between flaviviruses, but it appears to contain common secondary structural elements that influence the translation of flavivirus genomes.  However, the most significant function of the 5' NCR probably resides in its reverse complement, the 3' NCR of the viral minus strands, which forms the site for initiation of plus-strand synthesis (Lindenbach and Rice, 2001).  Replication begins with the synthesis of a genome-length  minus-strand RNA, which then serves as a template for the synthesis of additional plus-strand RNAs.  The first round of minus-strand accumulation has been detected in just over 3 hours after infection.  Viral RNA synthesis appears to be asymmetric in vivo, with a plus-strand accumulation more than 10 times greater than that of minus strands.  Virus minus strands appear to accumulate even late after infection and have been isolated exclusively in double-stranded forms (Lindenbach and Rice, 2001).  This mode of replication, with minus strands serving as templates for the production of multiple plus strands, can be described as semiconservative and asymmetric (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_334">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genomic RNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
A single input genome can give rise to multiple daughter genomes (Lindenbach and Rice, 2003).  RNA synthesis is asymmetric, leading to a 10- to 100-fold excess of positive strands over negative strands (Lindenbach and Rice, 2003).(<a href="#reference5335">Lindenbach et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_335">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleocapsid</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The nucleocapsid core of the mature virion consists of the genomic RNA surrounded by multiple copies of the capsid protein C (Zhang et al., 2003).  One of the earliest events in the flavivirus assembly is the formation of the NC, which consists of one copy of the genomic RNA and multiple copies of the capsid protein.  Unlike other enveloped viruses, NCs are rarely found in flavivirus-infected cells (although they can be assembled in vitro) which indicates that particle formation is a coordinated process between the membrane associated capsid protein and the prM-E heterodimers in the ER (Mukhopadhyay et al., 2005).(<a href="#reference5348">Zhang et al., 2003</a>)(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_336">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enveloped Nucleocapsid</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
This nucleocapsid core is envelped by a 40 A thick lipid bilayer derived from the endoplasmic reticulum of the host cell.  Outside the membrane envelope is a layer of 180 copies of the E glycoprotein organized into a herringbone pattern plus 180 copies of the M protein.  Both the E and M proteins are anchored in the membrane by their C-terminal domains (Zhang et al., 2003).  Because virion particles first become visible in the lumen of the rough endoplasmic reticulum (RER), it is generally believed that particle formation occurs by a still undefined assembly and budding process at the RER membrane (Heinz and Allison, 2003).  NCs are rarely found in flavivirus-infected cells (although they can be assembled in vitro) which indicates that particle formation is a coordinated process between the membrane associated capsid protein and the prM-E heterodimers in the ER (Mukhopadhyay et al., 2005).(<a href="#reference5348">Zhang et al., 2003</a>)(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)(<a href="#reference5343">Heinz et al., 2004</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_337">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enveloped Nucleocapsid</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Cryoimmunoelectron microscopy studies carried out with the Kunjin virus using drugs that inhibit intracellular protein and/or membrane transport support a maturation model that involves virion assembly in the ER, transport of individual particles in transport vesicles to the Golgi apparatus, movement through the individual stacks into the trans-Golgi region, accumulation within large vesicles, and release by exocytosis (Heinz and Allison, 2003).(<a href="#reference5343">Heinz et al., 2004</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_338">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mature Virion</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The apparently final maturation step for producing fully infectious virions is the proteolytic cleavage of the prM protein immediately after the sequence Arg-X-Arg/Lys-Arg, which corresponds to the consensus sequence for the cellular protease furin, and enzyme that is concentrated in the trans golgi network but cycles between endosomes and the plasma membrane as well (Heinz and Allison, 2003).(<a href="#reference5343">Heinz et al., 2004</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_339">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mature Virion</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
According to our best structural model, virions contain 180 copies of the E protein, an unknown amount of prM and C, and a single copy of the viral genome (Lindenbach and Rice, 2003).(<a href="#reference5335">Lindenbach et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_340">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Polyprotein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Genomic RNA is the messenger RNA for translation of a single long open reading frame RNA for translation of a single long open reading frame (ORF) as a large polyprotein (Lindenbach and Rice, 2001).  The flavivirus genome is translated as a large polyprotein that is processed co- and posttranslationally by cellular proteases and a virally encoded serine protease into at least 10 discrete products.  The N-terminal one quarter of the polyprotein encodes the structural proteins, and the remainder encodes the nonstructural (NS) proteins in the following order:  C-prM-E-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5 (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_341">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anch C</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The nascent C protein (anchC) contains a C-terminal hydrophobic domain that acts as a signal sequence for translocation of prM into the lumen of the endoplasmic reticulum (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_342">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Capsid Protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
C protein (about 11 kD) is highly basic, consistent with its proposed role in forming a ribonucleoprotein complex with packaged genomic RNA.  Basic residues are concentrated at the N- and C-termini of C, and they probably act cooperatively to specifically bind genomic RNA.  The central portion of C contains a hydrophobic domain that interacts with cellular membranes and may play a role in virion assembly (Lindenbach and Rice, 2001).  Mature C protein is generated by a serine protease cleavage at a site upstream of this hydrophobic domain (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_343">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS4A-NS4B</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Unprocessed NS3-4A and NS4A-4B have been detected in flavivirus-infected cells, suggesting that polyprotein cleavage in this region may be inefficient or controlled in additionally ways (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_344">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS3-NS4A</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Unprocessed NS3-4A and NS4A-4B have been detected in flavivirus-infected cells, suggesting that polyprotein cleavage in this region may be inefficient or controlled in additionally ways (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_345">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS4B</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
NS4A and NS4B are relatively small (about 16 kd and 27 kd) hydrophobic proteins that are membrane associated (Lindenbach and Rice, 2001).  NS4B also localized to presumed sites of RNA replication, but it also appears to be dispersed throughout cytoplasmic membranes and possibly the nucleus (Lindenbach and Rice, 2001).  NS4B is posttranslationally modified to a form that appears to be about 2 kd smaller than the nascent protein, although the nature of this modification is unknown (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_346">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS4B</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Nucleus"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
NS4B also localizes to presumed sites of RNA replication, but it also appears to be dispersed throughout cytoplasmic membranes, and possibly the nucleus (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_347">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS5</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
NS5, the largest (about 103 kd) and most conserved flavivirus protein, contains sequence homology to RdRPs of other positive-strand RNA viruses, including the invariant Gly-Asp-Asp (GDD) motif common to these enzymes (Lindenbach and Rice, 2001).  The NS5 gene of flaviviruses and pestiviruses has been proposed to encode the RNA-dependent RNA polymerase and, in the case of flaviviruses, also to encode a methyltransferase domain. NS5 of DEN-2 was shown to exist in different phosphorylated forms in nuclear and cytoplasmic fractions (Bartholomeusz and Thompson, 1999).  The conservation of NS3 and NS5 among flaviviruses and their homology with helicases and polymerases, respectively, suggest enzymatic roles in flavivirus RNA replication.  Although both proteins are present in subcellular fractions containing polymerase activity, most of the West Nile NS5 can be removed without significant loss of activity.  These investigators pointed out the possibility that only small quantities of replicase-associated NS5 are necessary for the observed polymerase activity (Chambers et al., 1990).(<a href="#reference5338">Bartholomeusz et al., 1999</a>)(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_348">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS5</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Nucleus"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Previous studies have reported that NS5 of two other flaviviruses is localized in the nucleus and cytoplasm of infected cells . This study, as shown by immunofluorescence, subcellular fractionation, and immunoprecipitation methods, shows that there are two forms of NS5 present in the cytoplasmic fraction that are separable by SDS-PAGE. Only the form with the slower mobility is predominantly located in the nuclear fraction. The multiple forms of NS5 are due to differential phosphorylation, and the hyperphosphorylated form is located predominantly in the nucleus (Kapoor et al., 1995).(<a href="#reference5342">Kapoor et al., 1995</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_349">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prM</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The nascent C protein (anchC) contains a C-terminal hydrophobic domain that acts as a signal sequence for translocation of prM into the lumen of the endoplasmic reticulum (Lindenbach and Rice, 2001).  The N-terminus of prM (about 26 kd) is generated in the ER by host signal peptidase.  This processing event appears to require prior processing of anchC by the cytoplasmic viral serine protease, although the temporal order of these cleavages has been questioned (Lindenbach and Rice, 2001).  The prM protein has two transmembrane-spanning domains, which contain a stop transfer sequence and a signal sequence (Mukhopadhyay et al., 2005).  prM is able to acquire its completely folded structure independently of E and appears to play a chaperone-like role for the folding of E (Heinz and Allison, 2003).(<a href="#reference5350">Lindenbach</a>)(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)(<a href="#reference5343">Heinz et al., 2004</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_350">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">E protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
E protein (about 50 kd) is a type I membrane protein,containing adjacent transmembrane domains in the C-terminus that serve to anchor this protein to the membrane and as the signal sequence for NS1 translocation (Lindenbach and Rice, 2001).  E protein homodimers disassociate at low pH, and each monomer reassociates with two adjacent E proteins, perhaps around a three-fold axis of symmetry at the stalk, to form trimeric complexes.  E trimers are thought to extend outward from the virion surface, presumably exposing the hydrophobic fusogenic domains.  The stem-anchor region of E, for which structure was not determined, contains determinants for E trimer formation and for stabilization of prM-E heterodimers (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_351">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prME</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Newly synthesized prM and E proteins associate together to form heterodimers (Heinz and Allison, 2003).  On the lumenal side of the ER, the prM and E proteins form a stable heterodimer within a few minutes of translation (Mukhopadhyay et al., 2005).(<a href="#reference5343">Heinz et al., 2004</a>)(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_352">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Subviral particle</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
A common characteristic of the flavivirus surface proteins prM/M and E is their ability to assemble into subviral particles, which are formed in variable amounts as a by product of flavivirus infection.  These subviral particles are smaller than infectious virions and do not contain a nucleocapsid  (Gehrke et al., 2003).  Subviral particles are also produced in the ER, but only contain the glycoproteins and membrane, and lack capsid protein and genomic RNA, making these particles non-infectious (Mukhopadhyay et al., 2005).  Initially, immature particles are formed in the lumen of the endoplasmic reticulum.  These particles, which contain E and prM proteins, lipid membrane, and NC, cannot induce host-cell fusion, making them non-infectious.  (Mukhopadhyay et al., 2005).(<a href="#reference5344">Gehrke et al., 2003</a>)(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_353">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Subviral particle</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Initially, immature particles are formed in the lumen of the endoplasmic reticulum.  These particles, which contain E and prM proteins, lipid membrane, and NC, cannot induce host-cell fusion, making them non-infectious  (Mukhopadhyay et al., 2005).  The resultant non-infectious, immature viral and subviral particles are transported through the trans-Golgi network  (Mukhopadhyay et al., 2005).(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_354">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Subviral particle</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
In addition to mature virions, smaller noninfectious particles are released from flavivirus-infected cells.  These particles are termed slowly sedimenting (70S) hemagglutinin (SHA) because like virions, they can agglutinate red blood cells at low pH.  SHA are smaller than virions (approximately 14 nm diameter).  These particles contain E and M proteins, but lack nucleocapsids (Lindenbach and Rice, 2003).  The released particles only contain the E and M proteins and a lipid membrane (Mukhopadhyay et al., 2005).(<a href="#reference5335">Lindenbach et al., 2003</a>)(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_355">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pr</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
During the egress of virions through the secretory pathway, prM is cleaved by the trans-Golgi resident enzyme furin, to form the structural protein M (about 8 kd) and the N-terminal 'pr' segment (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_356">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pr</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
During the egress of virions through the secretory pathway, prM is cleaved by the trans-Golgi resident enzyme furin, to form the structural protein M (about 8 kd) and the N-terminal 'pr' segment, which is secreted into the extracellular medium (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_357">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Recombinant Subviral Particle</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
A related or identical type of particle, recombinant subviral particles (RSP) can be produced by cells expressing prM and E alone. RSPs are 30 nm in diameter, less dense than viral particles, and can undergo acid-catalyzed fusion similar to virions (Lindenbach and Rice, 2003).  Recombinant subviral particles (RSPs) can also be generated by coexpression of proteins prM/M and E in the absence of protein C and have been shown to resemble whole virions with respect to their structural and functional organization of surface proteins (Gehrke et al., 2003).(<a href="#reference5335">Lindenbach et al., 2003</a>)(<a href="#reference5344">Gehrke et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_358">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS1</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_ER"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The NS1 glycoprotein (about 46kd) exists in cell-associated, cell-surface, or extracellular nonvirion forms.  NS1 is translocated into the ER lumen and released from the C-terminus of E by signal peptidase (Lindenbach and Rice, 2001).  NS1 is cleaved from its downstream neighbor, NS2A, about 10 minutes after synthesis by and unknown, membrane-bound, ER-resident host protease (Lindenbach and Rice, 2001).  Several lines of evidence implicate NS1 in the process of RNA replication (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_359">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS1</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
NS1 is slowly secreted from mammalian cells and is not secreted from mosquito cells.  During secretion, one of the N-linked glycans is modified to contain complex sugars, and three NS1 dimers come together into a soluble hexameric form (Lindenbach and Rice, 2001).  It is now understood that the extracellular forms of NS1 strongly elicit humoral immune responses, and immunization with purified or recombinant NS1 can be protective.  Furthermore, protective immunity can be passively transferred with antibodies against NS1, apparently by their ability to direct complement-mediated lysis of infected cells via interaction with the cell-surface-associated form of NS1.  The secretion of a viral NS protein that elicits protective immune responses is one of the more curious aspects of flavivirus biology that await further inquiry (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_360">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS2A</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Other"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
NS2A is a relatively small (about 22 kd), hydrophobic protein of unknown function (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_361">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS2A-alpha</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Other"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
In Yellow fever-infected cells, 22- and 20-kDa forms of NS2A have been identified and both of these forms possess the same N-terminal sequence.  The 20-kDa form (called NS2Aalpha) is believed to result from an additional internal cleavage by the NS2B-3 serine protease (Kummerer and Rice, 2002).  An alternative cleavage within Yellow Fever NS2a can also be utilized by the viral protease, leading to a c-terminally truncated form of this proteins that is about 2 kd smaller in mass (Lindenbach and Rice, 2001).(<a href="#reference5347">Kummerer et al., 2002</a>)(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_362">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS2B</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
NS2B is a small (about 14 kd) membrane-associated protein containing two hydrophobic domains surrounding a conserved hydrophilic region.  It forms a complex with NS3 and is a required cofactor for the serine protease function of NS3 (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_363">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS3</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
NS3 is a large (about 70 kd) cytoplasmic protein that associates with membranes via its interaction with NS2B.  NS3 contains several enzymatic activities that implicate this protein in polyprotein processing and RNA replication (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_364">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS4A</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
NS4A and NS4B are relatively small (about 16 kd and 27 kd) hydrophobic proteins that are membrane associated.  Based on its subcellular distribution and interaction with NS1, NS4A appears to function in RNA replication, perhaps by anchoring replicase components to cellular membranes (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_365">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS2B-3</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Other"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Enzyme.
The flavivirus protease is a complesx of NS2B and NS3 (Wu et al., 2003).  The NS2B-3 protease cleaves in both cis and trans configurations, and it mediates cleavages at the NS2A/NS2B, NS2B/NS3, NS3/NS4A, and NS4B/NS5 junctions, as well as cleavages that generate the C-termini of mature C and NS4A (Lindenbach and Rice, 2001).(<a href="#reference5349">Wu et al., 2003</a>)(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_366">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS2B-3</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Enzyme.
The flavivirus protease is a complesx of NS2B and NS3 (Wu et al., 2003).  The NS2B-3 protease cleaves in both cis and trans configurations, and it mediates cleavages at the NS2A/NS2B, NS2B/NS3, NS3/NS4A, and NS4B/NS5 junctions, as well as cleavages that generate the C-termini of mature C and NS4A (Lindenbach and Rice, 2001).(<a href="#reference5349">Wu et al., 2003</a>)(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_367">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NS2B-3</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Enzyme.
The flavivirus protease is a complex of NS2B and NS3 (Wu et al., 2003).  The NS2B-3 protease cleaves in both cis and trans configurations, and it mediates cleavages at the NS2A/NS2B, NS2B/NS3, NS3/NS4A, and NS4B/NS5 junctions, as well as cleavages that generate the C-termini of mature C and NS4A (Lindenbach and Rice, 2001).(<a href="#reference5349">Wu et al., 2003</a>)(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_368">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Replication Complex</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Other"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Nucleic acid binding.
To date, the flavivirus proteins: NS1, the NS3 helicase and the NS5 polymerase have been shown to be directly involved in flaviviral RNA replication and, in addition, NS2B and NS4B are co-localized with the RNA replication complex (Bartholomeusz and Thompson, 1999).  Model for the RNA replication cycle of the Flavivirus replication complex.  During translation of the ns proteins in cis from genomic RNA, NS3 is assumed to bind to the terminal product NS5 at one or more conserved regions in the N-terminal domain while other polyprotein cleavage products (NS1, NS2, and NS4A) move .  On completion of translation, assembly of the RC commences on the 3'UTR via binding of NS2A, probably at the conserved 3'- terminal stem loop at which the NS3 and NS5 components also bind.  The location of the complex shown on the loop is arbitrary.  The complex still attached to the RNA (+) stand is transported to the membrane site of replication by affinity of the hydrophobic regions of NS2A interacting with those of NS4A, which in turn is bound by its hydrophilic extensions into the lumen between transmembrane domains to dimeric NS1 in the lumen.  The RC is now complete and may undergo rearrangement as the RdRp domains of NS5 bind to the template, which circularizes (Westaway et al., 2003).(<a href="#reference5338">Bartholomeusz et al., 1999</a>)(<a href="#reference5341">Westaway et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_369">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Replication Complex</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Other"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Nucleic acid binding.
To date, the flavivirus proteins: NS1, the NS3 helicase and the NS5 polymerase have been shown to be directly involved in flaviviral RNA replication and, in addition, NS2B and NS4B are co-localized with the RNA replication complex (Bartholomeusz and Thompson, 1999).  Model for the RNA replication cycle of the Flavivirus replication complex.  During translation of the ns proteins in cis from genomic RNA, NS3 is assumed to bind to the terminal product NS5 at one or more conserved regions in the N-terminal domain while other polyprotein cleavage products (NS1, NS2, and NS4A) move .  On completion of translation, assembly of the RC commences on the 3'UTR via binding of NS2A, probably at the conserved 3'- terminal stem loop at which the NS3 and NS5 components also bind.  The location of the complex shown on the loop is arbitrary.  The complex still attached to the RNA (+) stand is transported to the membrane site of replication by affinity of the hydrophobic regions of NS2A interacting with those of NS4A, which in turn is bound by its hydrophilic extensions into the lumen between transmembrane domains to dimeric NS1 in the lumen.  The RC is now complete and may undergo rearrangement as the RdRp domains of NS5 bind to the template, which circularizes (Westaway et al., 2003).(<a href="#reference5338">Bartholomeusz et al., 1999</a>)(<a href="#reference5341">Westaway et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_370">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Replication Complex</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Other"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Nucleic acid binding.
To date, the flavivirus proteins: NS1, the NS3 helicase and the NS5 polymerase have been shown to be directly involved in flaviviral RNA replication and, in addition, NS2B and NS4B are co-localized with the RNA replication complex (Bartholomeusz and Thompson, 1999).  Model for the RNA replication cycle of the Flavivirus replication complex.  During translation of the ns proteins in cis from genomic RNA, NS3 is assumed to bind to the terminal product NS5 at one or more conserved regions in the N-terminal domain while other polyprotein cleavage products (NS1, NS2, and NS4A) move .  On completion of translation, assembly of the RC commences on the 3'UTR via binding of NS2A, probably at the conserved 3'- terminal stem loop at which the NS3 and NS5 components also bind.  The location of the complex shown on the loop is arbitrary.  The complex still attached to the RNA (+) stand is transported to the membrane site of replication by affinity of the hydrophobic regions of NS2A interacting with those of NS4A, which in turn is bound by its hydrophilic extensions into the lumen between transmembrane domains to dimeric NS1 in the lumen.  The RC is now complete and may undergo rearrangement as the RdRp domains of NS5 bind to the template, which circularizes (Westaway et al., 2003).(<a href="#reference5338">Bartholomeusz et al., 1999</a>)(<a href="#reference5341">Westaway et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_371">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pr</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
A pH-induced irreversible conformational change involving the prM and E proteins occurs in the trans-Golgi network, which is followed by cleavage of prM by furin (Mukhopadhyay et al., 2005).(<a href="#reference5339">Mukhopadhyay et al., 2005</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_372">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pr</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
During the egress of virions through the secretory pathway, prM is cleaved by the trans-Golgi resident enzyme furin, to form the structural protein M (about 8 kd) and the N-terminal 'pr' segment, which is secreted into the extracellular medium (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_373">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Furin</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Enzyme.
During the egress of virions through the secretory pathway, prM is cleaved by the trans-Golgi resident enzyme furin, to form the structural protein M (about 8 kd) and the N-terminal"pr" segment (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_374">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Furin</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Enzyme.
During the egress of virions through the secretory pathway, prM is cleaved by the trans-Golgi resident enzyme furin, to form the structural protein M (about 8 kd) and the N-terminal"pr" segment (Lindenbach and Rice, 2001).(<a href="#reference5350">Lindenbach</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
